Immuno-oncology Insights

IMMUNO-ONCOLOGY INSIGHTS

September 2024

Immuno-oncology Insights Vol 5 Issue 3
View Issue

Vol 5 Issue 3

Spotlight: Enhancing clinical development and patient stratification

View Spotlight

Upcoming webinars

Enhancing CAR-T efficacy for targeting lymphoma and solid tumors

Enhancing CAR-T efficacy for targeting lymphoma and solid tumors

Ruchi Patel
3 December
in 13
Days
Register
View all webinars

Latest Articles

Revolutionizing the treatment of cancer with allogeneic CAR-T cell therapy

Revolutionizing the treatment of cancer with allogeneic CAR-T cell therapy

Cokey Nguyen
13 November
Advancing cellular therapies: moving beyond the CAR-T landscape

Advancing cellular therapies: moving beyond the CAR-T landscape

Frank Borriello
4 September
Cellular immunotherapy—a matter of delivery?

Cellular immunotherapy—a matter of delivery?

Nina Bauer
4 September
Challenges and innovations in patient selection, biomarkers, and personalized treatments within the I-O landscape

Challenges and innovations in patient selection, biomarkers, and personalized treatments within the I-O landscape

Oliver Rosen
3 September
Patient-specific factors that could influence gene therapy outcomes in sickle cell disease

Patient-specific factors that could influence gene therapy outcomes in sickle cell disease

Abdulrahman Alsultan, Jaap Jan Boelens
1 September
Navigating the EU joint clinical assessment process: key considerations for manufacturers of ATMPs and oncology medicines

Navigating the EU joint clinical assessment process: key considerations for manufacturers of ATMPs and oncology medicines

Clare L Hague
17 June
Corrigendum to: Revolutionizing cancer treatment? A conversation on the potential of personalized cancer vaccines

Corrigendum to: Revolutionizing cancer treatment? A conversation on the potential of personalized cancer vaccines

Roy de Souza, David Hawke
29 May
Exploring the potential of combination radio-immunotherapy for a comprehensive cancer treatment

Exploring the potential of combination radio-immunotherapy for a comprehensive cancer treatment

Zachary Morris
3 April
Unraveling combination therapies in lung cancer: oncogenic drivers, ICI resistance, and predictive biomarkers

Unraveling combination therapies in lung cancer: oncogenic drivers, ICI resistance, and predictive biomarkers

Paul Hofman
27 March

Channel content